Increased Hepatic ACE2 Expression in NAFL and Diabetes-A Risk for COVID-19 Patients?

Soldo, Jelena; Heni, Martin; Königsrainer, Alfred; Häring, Hans-Ulrich; Birkenfeld, Andreas L; Peter, Andreas

Soldo, Jelena; Heni, Martin; Königsrainer, Alfred; Häring, Hans-Ulrich; Birkenfeld, Andreas L; Peter, Andreas.

Soldo J; Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany.
Heni M; Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany.
Königsrainer A; Division of Endocrinology, Diabetology and Nephrology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
Häring HU; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen, Tübingen, Germany.
Birkenfeld AL; German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.
Peter A; Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.

Diabetes Care ; 43(10): e134-e136, 2020 10.

Article in English | MEDLINE | ID: covidwho-697115

Subject(s)

Coronavirus Infections; Diabetes Mellitus; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Betacoronavirus; COVID-19; Humans; New York City; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Peptidyl-Dipeptidase A / Diabetes Mellitus / Pandemics Type of study: Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: Diabetes Care Year: 2020 Document Type: Article Affiliation country: Dc20-1458

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google